A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX

NCT04312815 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

510

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis(RA)

Interventions

DRUG: SM03
DRUG: Placebo
DRUG: MTX

Sponsor

SinoMab BioScience Ltd